产品编号 | 5.09703 |
品牌 | Sigma |
测定 | ≥98% (HPLC) |
警告 | Toxicity: Standard Handling (A) |
形式 | solid |
颜色 | off-white |
分子量 | 437.90 |
溶解性 | DMSO: 100 mg/mL |
储存温度 | 2-8°C |
质量水平 | 100 |
储存条件 | OK to freeze protect from light |
别名
LSD1 Inhibitor VII, SP-2509 - CAS 1423715-09-6 - Calbiochem,BHC110 Inhibitor VII, Histone Lysine Demethylase Inhibitor XIV, KIAA1718 Inhibitor VII, LSD Inhibitor VII, SP-2509
一般描述
A cell-permeable phenethylidene-benzohydrazide compound that acts as a potent, selective, reversible, and non-competitive inhibitor of Lysine-Specific Demethylase 1 (LSD1; IC50 = 13 nM; Ki = 31 nM). Exhibits excellent selectivity over monoamine oxidases A and B (IC50 >300 µM), lactate dehydrogenase, glucose oxidase, hERG, CYP1A2, CYP2D6 (IC50 ≥ 10 µM), CYP2C9 (IC50 = 8.04 µM) and CYP2C19 (IC50 = 9.76 µM). Inhibits CYP3A4 only at >200-fold higher concentration. Reduces the proliferation of several cancer cell lines, including AN3 Ca, BT-20, MCF-7, T-47D, HT29, MIA PaCa-2 and SK-N-MC (IC50 = 356, 489, 637, 649, 429, 468 and 329 nM, respectively).
A cell-permeable, lysine-specific demethylase 1 (LSD1) active site-targeting phenethylidene-benzohydrazide that inhibits LSD1 activity (IC50 = 13 nM) in a reversible and substrate non-competitive (Ki = 34 nM) manner, while inhibiting CYP3A4 only at much higher concentrations (IC50 = 2.61 µM) and displaying little or no potency towards CYP1A2/2C9/2C19/2D6. MAO-A/B, D-lactate dehydrogenase, glucose oxidase, and hERG (IC50 ≥8.0 µM). Shown to enhance histone H3 Lys9 dimethylation (H3K9me2) in androgen-dependent prostate cancer VCaP cultures (1 to 10 µM) and effectively inhibits LSD1-dependent cancer growth (IC50 in nM = 329/SK-N-MC, 356/AN3 Ca, 429/HT29, 468/MIA PaCa-2, 489/BT-20, 612/HER218, 614/HCT 116, 637/MCF-7, 649/T-47D; 96 h).
生化/生理作用
Cell permeable: yes
Primary Target
LSD1
Reversible: yes
重悬
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
其他说明
Fiskus, W., et al. 2014. Leukemia28, 2155.
Sorna, V., et al. 2013. J. Med. Chem.56, 9496.
关键字: LSD1 Inhibitor VII, SP-2509 - CAS 1423715-09-6 - Calbiochem;LSD1 Inhibitor VII, SP-2509 - CAS 1423715-09-6 - Calbiochem价格;LSD1 Inhibitor VII, SP-2509 - CAS 1423715-09-6 - Calbiochem厂家;1423715-09-6;Sigma
关于默克生命科学
我们拥有广泛的高质量产品组合和解决方案,致力于推动科学研究,提高药物研发和生物制药生产的质量和效率,并为获取准确可靠的诊断和检测结果提供安全的保障。我们的愿景是使全球各地的人们能够更快地获得提升人类健康水平的解决方案。我们的共同目标是通过与全球科学界合作,解决生命科学中棘手的问题。
30万个广泛产品组合,其中包括业内许多知名的品牌,Sigma-Alrdich?、Milli-Q?、 Supelco?、Millipore?、SAFC?和BioReliance?。
关于默克
是一家全球领先的科技公司,专注于医药健康、生命科学和电子科技三大领域。全球约有57,000名员工服务于默克,通过创造更加愉悦和可持续性的生活方式,为数百万人的生活带来积极的影响。从先进的基因编辑技术和发现治疗最具挑战性疾病的独特方法,到实现设备的智能化——默克无处不在。
科学探索和负责任的企业精神一直是默克科技进步的关键,也是默克自1668年以来永葆活力的秘诀。默克家族作为公司的创始者至今仍持有默克大部分的股份,我们在全球都叫“默克”,仅美国和加拿大例外。默克的三大领域:医药健康、生命科学及电子科技在这两个国家分别称之为“EMD Serono”、“MilliporeSigma”和“EMD Electronics”。
默克在中国已经有87年发展历史,目前有超过4100名员工,在